EUVIMEDEUVIMED entdecken
Crossref

Clinical utility of targeted next‐generation sequencing panel in routine diagnosis of hereditary hemolytic anemia: A national reference laboratory experience

Archana M Agarwal, Valarie McMurty iD, Adam L Clayton, Ashini Bolia, N Scott Reading iD, Coumarane Mani, Jay L Patel iD, Anton Rets

European Journal of Haematology · 2023

DOI: 10.1111/ejh.13951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2023. Verfasst von Archana M Agarwal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Utah Health and ARUP Laboratories, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Congenital, Elliptocytosis, Hereditary, Spherocytosis, Hereditary. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hereditary hemolytic anemias (HHA) comprise a heterogeneous group of disorders resulting from defective red blood cell (RBC) cytoskeleton, RBC enzyme deficiencies, and hemoglobin (Hb) synthesis disorders such as thalassemia or sideroblastic anemia. Materials and Methods Our hemolytic anemia diagnostic next‐generation sequencing (NGS) panel includes 28 genes encoding RBC cytoskeletal proteins, membrane transporter, RBC enzymes, and certain bilirubin metabolism genes. The panel covers the complete coding region of these genes, splice junctions, and, wherever appropriate, deep intronic or regulatory regions are also included. Four hundred fifty‐six patients with unexplained hemolytic anemia were evaluated using our NGS panel between 2015 and 2019.

Results

We identified pathogenic/likely pathogenic variants in 111/456 (24%) patients that were responsible for the disease phenotype (e.g., moderate to severe hemolytic anemia and hyperbilirubinemia). Approximately 40% of the mutations were novel. As expected, 45/456 (10%) patients were homozygous for the promoter polymorphism in the UGT1A1 gene, A(TA) 7 TAA ( UGT1A1 *28). 8/45 homozygous UGT1A1 *28 cases were associated with additional pathogenic mutations causing hemolytic anemia, likely exacerbating hyperbilirubinemia. The most common mutated genes were membrane cytoskeleton genes SPTA1, and SPTB , followed by PKLR. Complex interactions between SPTA1 low expression alleles , alpha‐LELY and alpha‐LEPRA alleles, and intragenic SPTA1 variants were associated with hereditary pyropoikilocytosis and autosomal recessive hereditary spherocytosis in 23/111 patients.

Conclusions

Our results demonstrate that hemolytic anemia is underscored by complex molecular interactions of previously known and novel mutations in RBC cytoskeleton/enzyme genes, and therefore, NGS should be considered in all patients with clinically unexplained hemolytic anemia and in neonates with hyperbilirubinemia. Moreover, low expression alleles alpha‐LELY and alpha‐LEPRA should be included in all targeted HHA panels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Hemolytic, CongenitalElliptocytosis, HereditarySpherocytosis, HereditaryHumansCytoskeletal ProteinsHyperbilirubinemiaHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

hereditary hemolytic anemiamolecular diagnosisnext-generation sequencingred blood cell

Substanzen

Cytoskeletal Proteins

Autor:innen und Institutionen

  • Department of Pathology, University of Utah Health and ARUP Laboratories, Salt Lake City, Utah, USA.
  • ARUP Laboratories, Salt Lake City, Utah, USA.
  • Department of Internal Medicine, Hematology Division, University of Utah Health, Salt Lake City, Utah, USA.

ORCID-Profile: Valarie McMurty, N Scott Reading, Jay L Patel

Zitieren

APA

Agarwal, A. M., McMurty, V., Clayton, A. L., Bolia, A., Reading, N. S., Mani, C., Patel, J. L., & Rets, A. (2023). Clinical utility of targeted next‐generation sequencing panel in routine diagnosis of hereditary hemolytic anemia: A national reference laboratory experience. European Journal of Haematology. https://doi.org/10.1111/ejh.13951

Vancouver

Agarwal AM, McMurty V, Clayton AL, Bolia A, Reading NS, Mani C, et al. Clinical utility of targeted next‐generation sequencing panel in routine diagnosis of hereditary hemolytic anemia: A national reference laboratory experience. European Journal of Haematology. 2023. doi:10.1111/ejh.13951

BibTeX
@article{Agarwal2023,
  author = {Agarwal, Archana M and McMurty, Valarie and Clayton, Adam L and Bolia, Ashini and Reading, N Scott and Mani, Coumarane and Patel, Jay L and Rets, Anton},
  title = {Clinical utility of targeted next‐generation sequencing panel in routine diagnosis of hereditary hemolytic anemia: A national reference laboratory experience},
  journal = {European Journal of Haematology},
  year = {2023},
  doi = {10.1111/ejh.13951}
}
Kostenlos starten →